Please use this identifier to cite or link to this item:
|Title:||Feasibility of progesterone treatment for ischaemic stroke|
|Authors:||Gibson, Claire L.|
Bath, Philip M.
|Citation:||Journal of Cerebral Blood Flow and Metabolism, 2016, 36 (3), pp. 487-491|
|Abstract:||Two multi-centre phase III clinical trials examining the protective potential of progesterone following traumatic brain injury have recently failed to demonstrate any improvement in outcome. Thus, it is timely to consider how this impacts on the translational potential of progesterone treatment for ischaemic stroke. A wealth of experimental evidence supports the neuroprotective properties of progesterone, and associated metabolites, following various types of central nervous system injury. In particular, for ischaemic stroke, studies have also begun to reveal possible mechanisms of such neuroprotection. However, the results in traumatic brain injury now question whether further clinical development of progesterone for ischaemic stroke is relevant.|
|Rights:||Copyright © the authors, 2015. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.|
|Appears in Collections:||Reports, Dept. of Neuroscience, Psychology and Behaviour|
Files in This Item:
|Feasibility of progesterone treatment for ischaemic stroke.pdf||Published (publisher PDF)||221.29 kB||Adobe PDF||View/Open|
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.